189 related articles for article (PubMed ID: 30557966)
1. Effect of adjuvant hormone therapy in patients with prostate cancer: A meta-analysis of randomized controlled trials.
Liu F; Sun D; Zhou X; Ding Y; Ma Y; Hou Y; Kong X; Wang Z
Medicine (Baltimore); 2018 Dec; 97(50):e13145. PubMed ID: 30557966
[TBL] [Abstract][Full Text] [Related]
2. Adjuvant hormone therapy for localised and locally advanced prostate carcinoma: a systematic review and meta-analysis of randomised trials.
Shelley MD; Kumar S; Coles B; Wilt T; Staffurth J; Mason MD
Cancer Treat Rev; 2009 Nov; 35(7):540-6. PubMed ID: 19493624
[TBL] [Abstract][Full Text] [Related]
3. The effects of idarubicin versus other anthracyclines for induction therapy of patients with newly diagnosed leukaemia.
Li X; Xu S; Tan Y; Chen J
Cochrane Database Syst Rev; 2015 Jun; (6):CD010432. PubMed ID: 26037486
[TBL] [Abstract][Full Text] [Related]
4. Intravesical Bacillus Calmette-Guérin with interferon-alpha versus intravesical Bacillus Calmette-Guérin for treating non-muscle-invasive bladder cancer.
Shepherd AR; Shepherd E; Brook NR
Cochrane Database Syst Rev; 2017 Mar; 3(3):CD012112. PubMed ID: 28268259
[TBL] [Abstract][Full Text] [Related]
5. Adjuvant Chemotherapy in High-Risk Prostate Cancer Patients after Primary Local Therapy: Recurrence, Metastasis, and Survival - A Meta-Analysis.
Zhang Q; Huang J; Xie C; Wu T
Urol Int; 2021; 105(5-6):394-401. PubMed ID: 33784714
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and toxicity of extended aromatase inhibitors after adjuvant aromatase inhibitors-containing therapy for hormone-receptor-positive breast cancer: a literature-based meta-analysis of randomized trials.
Qian X; Li Z; Ruan G; Tu C; Ding W
Breast Cancer Res Treat; 2020 Jan; 179(2):275-285. PubMed ID: 31606823
[TBL] [Abstract][Full Text] [Related]
7. Chemotherapy alone versus chemotherapy plus radiotherapy for adults with early stage Hodgkin lymphoma.
Blank O; von Tresckow B; Monsef I; Specht L; Engert A; Skoetz N
Cochrane Database Syst Rev; 2017 Apr; 4(4):CD007110. PubMed ID: 28447341
[TBL] [Abstract][Full Text] [Related]
8. Neoadjuvant hormone therapy for patients with high-risk prostate cancer: a systematic review and meta-analysis.
Liu W; Yao Y; Liu X; Liu Y; Zhang GM
Asian J Androl; 2021; 23(4):429-436. PubMed ID: 33586699
[TBL] [Abstract][Full Text] [Related]
9. Ovarian suppression for adjuvant treatment of hormone receptor-positive early breast cancer.
Bui KT; Willson ML; Goel S; Beith J; Goodwin A
Cochrane Database Syst Rev; 2020 Mar; 3(3):CD013538. PubMed ID: 32141074
[TBL] [Abstract][Full Text] [Related]
10. Adjuvant radiation with hormonal therapy is associated with improved survival in men with pathologically involved lymph nodes after radical surgery for prostate cancer.
Wong AT; Schwartz D; Osborn V; Safdieh J; Weiner J; Schreiber D
Urol Oncol; 2016 Dec; 34(12):529.e15-529.e20. PubMed ID: 27443637
[TBL] [Abstract][Full Text] [Related]
11. Screening for prostate cancer.
Ilic D; Neuberger MM; Djulbegovic M; Dahm P
Cochrane Database Syst Rev; 2013 Jan; 2013(1):CD004720. PubMed ID: 23440794
[TBL] [Abstract][Full Text] [Related]
12. Neo-adjuvant hormone therapy for non-metastatic prostate cancer: a systematic review and meta-analysis of 5,194 patients.
Hu J; Xu H; Zhu W; Wu F; Wang J; Ding Q; Jiang H
World J Surg Oncol; 2015 Feb; 13():73. PubMed ID: 25884478
[TBL] [Abstract][Full Text] [Related]
13. Bisphosphonates in multiple myeloma: a network meta-analysis.
Mhaskar R; Redzepovic J; Wheatley K; Clark OA; Miladinovic B; Glasmacher A; Kumar A; Djulbegovic B
Cochrane Database Syst Rev; 2012 May; (5):CD003188. PubMed ID: 22592688
[TBL] [Abstract][Full Text] [Related]
14. Adjuvant Hormone Therapy May Improve Survival in Epithelial Ovarian Cancer: Results of the AHT Randomized Trial.
Eeles RA; Morden JP; Gore M; Mansi J; Glees J; Wenczl M; Williams C; Kitchener H; Osborne R; Guthrie D; Harper P; Bliss JM
J Clin Oncol; 2015 Dec; 33(35):4138-44. PubMed ID: 26417001
[TBL] [Abstract][Full Text] [Related]
15. Long-term utility of adjuvant hormonal and radiation therapy for patients with seminal vesicle invasion at radical prostatectomy.
Moschini M; Sharma V; Gandaglia G; Dell'Oglio P; Fossati N; Zaffuto E; Montorsi F; Briganti A; Karnes RJ
BJU Int; 2017 Jul; 120(1):69-75. PubMed ID: 27753192
[TBL] [Abstract][Full Text] [Related]
16. Neo-adjuvant and adjuvant hormone therapy for localised and locally advanced prostate cancer.
Kumar S; Shelley M; Harrison C; Coles B; Wilt TJ; Mason MD
Cochrane Database Syst Rev; 2006 Oct; 2006(4):CD006019. PubMed ID: 17054269
[TBL] [Abstract][Full Text] [Related]
17. Extended Adjuvant Therapy With Aromatase Inhibitors for Early Breast Cancer: A Meta-analysis of Randomized Controlled Trials.
Xu L; Zhang Z; Xiang Q; Liu Q; Duan X; Liu Y; Cui Y
Clin Breast Cancer; 2019 Oct; 19(5):e578-e588. PubMed ID: 31257015
[TBL] [Abstract][Full Text] [Related]
18. Adjuvant (post-surgery) chemotherapy for early stage epithelial ovarian cancer.
Lawrie TA; Winter-Roach BA; Heus P; Kitchener HC
Cochrane Database Syst Rev; 2015 Dec; 2015(12):CD004706. PubMed ID: 26676202
[TBL] [Abstract][Full Text] [Related]
19. Single or combined immune checkpoint inhibitors compared to first-line platinum-based chemotherapy with or without bevacizumab for people with advanced non-small cell lung cancer.
Ferrara R; Imbimbo M; Malouf R; Paget-Bailly S; Calais F; Marchal C; Westeel V
Cochrane Database Syst Rev; 2020 Dec; 12(12):CD013257. PubMed ID: 33316104
[TBL] [Abstract][Full Text] [Related]
20. Association of Adjuvant Hormone Therapy Timing With Overall Survival Among Patients With Hormone Receptor-Positive Human Epidermal Growth Factor Receptor-2-Negative Early Breast Cancer Without Chemotherapy.
Fu F; Yu L; Zeng B; Chen M; Guo W; Chen L; Lin Y; Hou J; Li J; Li Y; Li S; Chen X; Zhang W; Jin X; Cai W; Zhang K; Chen H; Qiu Y; Nie Q; Wang C; Jacobs L
JAMA Netw Open; 2022 Feb; 5(2):e2145934. PubMed ID: 35166783
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
